Lung clearance index (LCI 2.5 ) changes after initiation of Elexacaftor/Tezacaftor/Ivacaftor in children with cystic fibrosis aged between 6 and 11 years: The "real-world" differs from trial data.
Donald S UrquhartHeather DowleKellie MoffatJody ForsterSteve CunninghamKenneth A MacleodPublished in: Pediatric pulmonology (2024)
values being recorded in the real world of children with CF.